Phreesia, Inc. (PHR): Price and Financial Metrics

Phreesia, Inc. (PHR): $26.71

0.66 (+2.53%)

POWR Rating

Component Grades














  • Sentiment is the dimension where PHR ranks best; there it ranks ahead of 68.26% of US stocks.
  • PHR's strongest trending metric is Growth; it's been moving up over the last 26 weeks.
  • PHR's current lowest rank is in the Value metric (where it is better than 10.18% of US stocks).

PHR Stock Summary

  • For PHR, its debt to operating expenses ratio is greater than that reported by just 9.18% of US equities we're observing.
  • Equity multiplier, or assets relative to shareholders' equity, comes in at 1.19 for PHREESIA INC; that's greater than it is for just 12.89% of US stocks.
  • In terms of twelve month growth in earnings before interest and taxes, PHREESIA INC is reporting a growth rate of 269.09%; that's higher than 93.61% of US stocks.
  • If you're looking for stocks that are quantitatively similar to PHREESIA INC, a group of peers worth examining would be RELY, NVVE, DMTK, BMRA, and LMND.
  • Visit PHR's SEC page to see the company's official filings. To visit the company's web site, go to

PHR Valuation Summary

  • In comparison to the median Technology stock, PHR's price/sales ratio is 139.13% higher, now standing at 5.5.
  • PHR's price/sales ratio has moved down 3.3 over the prior 41 months.

Below are key valuation metrics over time for PHR.

Stock Date P/S P/B P/E EV/EBIT
PHR 2022-12-06 5.5 3.9 -7.5 -6.3
PHR 2022-12-05 6.0 4.2 -8.1 -6.9
PHR 2022-12-02 6.1 4.3 -8.3 -7.1
PHR 2022-12-01 6.0 4.2 -8.2 -7.0
PHR 2022-11-30 6.0 4.2 -8.1 -6.9
PHR 2022-11-29 5.5 3.9 -7.5 -6.2

PHR's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • PHR has a Quality Grade of D, ranking ahead of 21% of graded US stocks.
  • PHR's asset turnover comes in at 0.404 -- ranking 372nd of 561 Business Services stocks.
  • 500 - Internal server error

The table below shows PHR's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-07-31 0.404 0.628 -0.958
2021-04-30 0.472 0.639 -0.563
2021-01-31 0.603 0.648 -0.474
2020-10-31 0.683 0.651 -0.415
2020-07-31 0.843 0.656 -0.373
2020-04-30 0.813 0.651 -0.432

PHR Price Target

For more insight on analysts targets of PHR, see our PHR price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $73.50 Average Broker Recommendation 1.4 (Strong Buy)

PHR Stock Price Chart Interactive Chart >

Price chart for PHR

PHR Price/Volume Stats

Current price $26.71 52-week high $49.86
Prev. close $26.05 52-week low $13.19
Day low $25.77 Volume 313,001
Day high $26.99 Avg. volume 525,433
50-day MA $25.21 Dividend yield N/A
200-day MA $24.54 Market Cap 1.40B

Phreesia, Inc. (PHR) Company Bio

Phreesia, Inc. provides patient check-in solutions for medical practices. It provides solutions that transform the healthcare experience by engaging patients in their care and enabling healthcare provider organizations to optimize operational efficiency, improve profitability and enhance clinical care. Through the SaaS-based Phreesia Platform the company offers healthcare provider organizations a robust suite of solutions to manage the patient intake process and a payments solution for secure processing of patient payments. Its platform also provides life sciences companies with an engagement channel for targeted and direct communication with patients. Phreesia was founded by Chaim Indig and Evan Roberts in January 2005 and is headquartered in New York, NY.

PHR Latest News Stream

Event/Time News Detail
Loading, please wait...

PHR Latest Social Stream

Loading social stream, please wait...

View Full PHR Social Stream

Latest PHR News From Around the Web

Below are the latest news stories about PHREESIA INC that investors may wish to consider to help them evaluate PHR as an investment opportunity.

Phreesia Q3 2023 Earnings Preview

Phreesia’s Sara DiNardo Selected as a Top Woman Leader in SaaS

WILIMINGTON, Del., November 16, 2022--Phreesia is proud to announce that Sara DiNardo, the company’s Vice President of Client Solutions, has been named to The Software Report’s list of the Top 50 Women Leaders in SaaS of 2022.

Yahoo | November 16, 2022

MEI Pharma, Inc. (MEIP) Reports Q1 Loss, Lags Revenue Estimates

MEI Pharma, Inc. (MEIP) delivered earnings and revenue surprises of 0% and 10.46%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Yahoo | November 14, 2022

Neovasc (NVCN) Reports Q3 Loss, Misses Revenue Estimates

Neovasc (NVCN) delivered earnings and revenue surprises of -6.38% and 7.70%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Yahoo | November 11, 2022

Cue Health Inc. (HLTH) Reports Q3 Loss, Tops Revenue Estimates

Cue Health Inc. (HLTH) delivered earnings and revenue surprises of 21.82% and 19.92%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Yahoo | November 9, 2022

Read More 'PHR' Stories Here

PHR Price Returns

1-mo 16.38%
3-mo -6.48%
6-mo 36.28%
1-year -50.54%
3-year -7.67%
5-year N/A
YTD -35.89%
2021 -23.22%
2020 103.68%
2019 N/A
2018 N/A
2017 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.7848 seconds.